Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guocan Yu

Showing results (131-140 of 239) with videos related to

Pageof 24
Sort By:
Infection and Drug Resistance|March 26, 2026
Temporal Disease Sequence and Prognostic Outcomes in Patients with Coexisting Lung Cancer and Tuberculosis: A 123-Patient Retrospective Cohort StudyWenfeng Yu, Haoran Xie, Bo Ye, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 10, 2019
[2]Pseudorotaxane-Based Supramolecular Optical Indicator for the Visual Detection of Cellular Cyanide ExcretionJiong Zhou, Guocan Yu, Yang Li, et al.
Acta Biomaterialia|October 23, 2025
Corrigendum to "Dynamically assembled nanomedicine based on host-guest molecular recognition for NIR laser-excited chemotherapy and phototheranostics" [Acta Biomaterilia. Volume 168, 15 September 2023, Pages 565-579]Dan Wu, Zhankui Zhang, Xinyue Li, et al.
Journal of Nanobiotechnology|July 31, 2025
Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinomaWanyue Cao, Kai Yang, Gaowei Jin, et al.
Acta Pharmaceutica Sinica. B|June 9, 2025
Inhaled non-viral delivery systems for RNA therapeuticsCheng Huang, Hongjian Li, Xing Duan, et al.
Journal of Nanobiotechnology|October 11, 2025
Correction: Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinomaWanyue Cao, Kai Yang, Gaowei Jin, et al.
ACS Applied Materials & Interfaces|December 6, 2017
Supramolecular Nanomedicine Constructed from Cucurbit[8]uril-Based Amphiphilic Brush Copolymer for Cancer TherapyDan Wu, Yang Li, Jie Yang, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 6, 2019
X-ray-Controlled Bilayer Permeability of Bionic Nanocapsules Stabilized by Nucleobase Pairing Interactions for Pulsatile Drug DeliveryHongzhang Deng, Lisen Lin, Sheng Wang, et al.
Theranostics|September 28, 2022
Circular RNA cancer vaccines drive immunity in hard-to-treat malignanciesHongjian Li, Kun Peng, Kai Yang, et al.
Journal of Nanobiotechnology|October 21, 2021
Evaluation of the stability of cucurbit[8]uril-based ternary host-guest complexation in physiological environment and the fabrication of a supramolecular theranostic nanomedicineHan Wu, Zuobing Chen, Shaolong Qi, et al.
Pageof 24

Showing results (131-140 of 239) with videos related to

Sort By:
Pageof 24
Infection and Drug Resistance|March 26, 2026
Temporal Disease Sequence and Prognostic Outcomes in Patients with Coexisting Lung Cancer and Tuberculosis: A 123-Patient Retrospective Cohort StudyWenfeng Yu, Haoran Xie, Bo Ye, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 10, 2019
[2]Pseudorotaxane-Based Supramolecular Optical Indicator for the Visual Detection of Cellular Cyanide ExcretionJiong Zhou, Guocan Yu, Yang Li, et al.
Acta Biomaterialia|October 23, 2025
Corrigendum to "Dynamically assembled nanomedicine based on host-guest molecular recognition for NIR laser-excited chemotherapy and phototheranostics" [Acta Biomaterilia. Volume 168, 15 September 2023, Pages 565-579]Dan Wu, Zhankui Zhang, Xinyue Li, et al.
Journal of Nanobiotechnology|July 31, 2025
Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinomaWanyue Cao, Kai Yang, Gaowei Jin, et al.
Acta Pharmaceutica Sinica. B|June 9, 2025
Inhaled non-viral delivery systems for RNA therapeuticsCheng Huang, Hongjian Li, Xing Duan, et al.
Journal of Nanobiotechnology|October 11, 2025
Correction: Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinomaWanyue Cao, Kai Yang, Gaowei Jin, et al.
ACS Applied Materials & Interfaces|December 6, 2017
Supramolecular Nanomedicine Constructed from Cucurbit[8]uril-Based Amphiphilic Brush Copolymer for Cancer TherapyDan Wu, Yang Li, Jie Yang, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 6, 2019
X-ray-Controlled Bilayer Permeability of Bionic Nanocapsules Stabilized by Nucleobase Pairing Interactions for Pulsatile Drug DeliveryHongzhang Deng, Lisen Lin, Sheng Wang, et al.
Theranostics|September 28, 2022
Circular RNA cancer vaccines drive immunity in hard-to-treat malignanciesHongjian Li, Kun Peng, Kai Yang, et al.
Journal of Nanobiotechnology|October 21, 2021
Evaluation of the stability of cucurbit[8]uril-based ternary host-guest complexation in physiological environment and the fabrication of a supramolecular theranostic nanomedicineHan Wu, Zuobing Chen, Shaolong Qi, et al.
Pageof 24